HEADER IMMUNE SYSTEM 12-FEB-18 6FPV TITLE A LLAMA-DERIVED JBP1-TARGETING NANOBODY COMPND MOL_ID: 1; COMPND 2 MOLECULE: NANOBODY; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: LAMA GLAMA; SOURCE 3 ORGANISM_COMMON: LLAMA; SOURCE 4 ORGANISM_TAXID: 9844; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_VARIANT: WK6; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: CA12626 KEYWDS NANOBODY, JBP1, LLAMA, IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR B.VAN BEUSEKOM,A.ADAMOPOULOS,T.HEIDEBRECHT,R.P.JOOSTEN,A.PERRAKIS REVDAT 3 17-JAN-24 6FPV 1 REMARK REVDAT 2 14-NOV-18 6FPV 1 JRNL REVDAT 1 31-OCT-18 6FPV 0 JRNL AUTH B.VAN BEUSEKOM,T.HEIDEBRECHT,A.ADAMOPOULOS,A.FISH,E.PARDON, JRNL AUTH 2 J.STEYAERT,R.P.JOOSTEN,A.PERRAKIS JRNL TITL CHARACTERIZATION AND STRUCTURE DETERMINATION OF A JRNL TITL 2 LLAMA-DERIVED NANOBODY TARGETING THE J-BASE BINDING PROTEIN JRNL TITL 3 1. JRNL REF ACTA CRYSTALLOGR F STRUCT V. 74 690 2018 JRNL REF 2 BIOL COMMUN JRNL REFN ESSN 2053-230X JRNL PMID 30387773 JRNL DOI 10.1107/S2053230X18010282 REMARK 2 REMARK 2 RESOLUTION. 1.64 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REFMAC_5.8.0208 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.64 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 49.95 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 28065 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.165 REMARK 3 R VALUE (WORKING SET) : 0.163 REMARK 3 FREE R VALUE : 0.195 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1463 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1844 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 18 REMARK 3 SOLVENT ATOMS : 150 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 29.32 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.04000 REMARK 3 B22 (A**2) : 0.04000 REMARK 3 B33 (A**2) : -0.11000 REMARK 3 B12 (A**2) : 0.02000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.089 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.089 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.066 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.045 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : NULL ; NULL REMARK 3 ANGLE DISTANCE (A) : NULL ; NULL REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : NULL ; NULL REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : NULL ; NULL REMARK 3 STAGGERED (DEGREES) : NULL ; NULL REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 6FPV COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 12-FEB-18. REMARK 100 THE DEPOSITION ID IS D_1200008622. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-SEP-17 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 3.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : MASSIF-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.96600 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : CRL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 2M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.5.32 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 40857 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.470 REMARK 200 RESOLUTION RANGE LOW (A) : 49.950 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 5.100 REMARK 200 R MERGE (I) : 0.05100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.47 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.52 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.4 REMARK 200 DATA REDUNDANCY IN SHELL : 5.10 REMARK 200 R MERGE FOR SHELL (I) : 1.38200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER 2.7.17 REMARK 200 STARTING MODEL: 3EZJ REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.94 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.16 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.3M CITRIC ACID PH 3.5; 25% W/V REMARK 280 POLYETHYLENE GLYCOL 3350, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 21.58367 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 43.16733 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 0 REMARK 465 LYS A 1 REMARK 465 TYR A 2 REMARK 465 LEU A 3 REMARK 465 LEU A 4 REMARK 465 PRO A 5 REMARK 465 THR A 6 REMARK 465 ALA A 7 REMARK 465 ALA A 8 REMARK 465 ALA A 9 REMARK 465 GLY A 10 REMARK 465 LEU A 11 REMARK 465 LEU A 12 REMARK 465 LEU A 13 REMARK 465 LEU A 14 REMARK 465 ALA A 15 REMARK 465 ALA A 16 REMARK 465 GLN A 17 REMARK 465 PRO A 18 REMARK 465 ALA A 19 REMARK 465 MET A 20 REMARK 465 ALA A 21 REMARK 465 HIS A 144 REMARK 465 HIS A 145 REMARK 465 HIS A 146 REMARK 465 HIS A 147 REMARK 465 HIS A 148 REMARK 465 HIS A 149 REMARK 465 GLU A 150 REMARK 465 PRO A 151 REMARK 465 GLU A 152 REMARK 465 ALA A 153 REMARK 465 MET B 0 REMARK 465 LYS B 1 REMARK 465 TYR B 2 REMARK 465 LEU B 3 REMARK 465 LEU B 4 REMARK 465 PRO B 5 REMARK 465 THR B 6 REMARK 465 ALA B 7 REMARK 465 ALA B 8 REMARK 465 ALA B 9 REMARK 465 GLY B 10 REMARK 465 LEU B 11 REMARK 465 LEU B 12 REMARK 465 LEU B 13 REMARK 465 LEU B 14 REMARK 465 ALA B 15 REMARK 465 ALA B 16 REMARK 465 GLN B 17 REMARK 465 PRO B 18 REMARK 465 ALA B 19 REMARK 465 MET B 20 REMARK 465 ALA B 21 REMARK 465 SER B 143 REMARK 465 HIS B 144 REMARK 465 HIS B 145 REMARK 465 HIS B 146 REMARK 465 HIS B 147 REMARK 465 HIS B 148 REMARK 465 HIS B 149 REMARK 465 GLU B 150 REMARK 465 PRO B 151 REMARK 465 GLU B 152 REMARK 465 ALA B 153 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 87 NE - CZ - NH2 ANGL. DEV. = -3.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 69 -63.92 -106.68 REMARK 500 VAL B 69 -61.43 -105.33 REMARK 500 TYR B 125 -39.25 -35.40 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL B 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL B 202 DBREF 6FPV A 0 153 PDB 6FPV 6FPV 0 153 DBREF 6FPV B 0 153 PDB 6FPV 6FPV 0 153 SEQRES 1 A 154 MET LYS TYR LEU LEU PRO THR ALA ALA ALA GLY LEU LEU SEQRES 2 A 154 LEU LEU ALA ALA GLN PRO ALA MET ALA GLN VAL GLN LEU SEQRES 3 A 154 VAL GLU SER GLY GLY GLY LEU VAL GLN ALA GLY GLY SER SEQRES 4 A 154 LEU ARG LEU SER CYS ALA ALA SER GLY SER PHE PHE SER SEQRES 5 A 154 ILE ASN ASP MET GLY TRP TYR ARG GLN ALA PRO GLY LYS SEQRES 6 A 154 GLN ARG GLU LEU VAL ALA VAL ILE SER SER GLY GLY SER SEQRES 7 A 154 THR ASN TYR ALA ASP SER VAL GLU GLY ARG SER THR ILE SEQRES 8 A 154 SER SER ASP ASN ALA LYS ASN THR VAL TYR LEU GLN LEU SEQRES 9 A 154 SER SER LEU LYS PRO GLU ASP THR ALA VAL TYR TYR CYS SEQRES 10 A 154 ASN ALA ASN VAL ARG LEU ARG GLU TYR ARG THR THR SER SEQRES 11 A 154 TYR HIS TYR TRP GLY GLN GLY THR GLN VAL THR VAL SER SEQRES 12 A 154 SER HIS HIS HIS HIS HIS HIS GLU PRO GLU ALA SEQRES 1 B 154 MET LYS TYR LEU LEU PRO THR ALA ALA ALA GLY LEU LEU SEQRES 2 B 154 LEU LEU ALA ALA GLN PRO ALA MET ALA GLN VAL GLN LEU SEQRES 3 B 154 VAL GLU SER GLY GLY GLY LEU VAL GLN ALA GLY GLY SER SEQRES 4 B 154 LEU ARG LEU SER CYS ALA ALA SER GLY SER PHE PHE SER SEQRES 5 B 154 ILE ASN ASP MET GLY TRP TYR ARG GLN ALA PRO GLY LYS SEQRES 6 B 154 GLN ARG GLU LEU VAL ALA VAL ILE SER SER GLY GLY SER SEQRES 7 B 154 THR ASN TYR ALA ASP SER VAL GLU GLY ARG SER THR ILE SEQRES 8 B 154 SER SER ASP ASN ALA LYS ASN THR VAL TYR LEU GLN LEU SEQRES 9 B 154 SER SER LEU LYS PRO GLU ASP THR ALA VAL TYR TYR CYS SEQRES 10 B 154 ASN ALA ASN VAL ARG LEU ARG GLU TYR ARG THR THR SER SEQRES 11 B 154 TYR HIS TYR TRP GLY GLN GLY THR GLN VAL THR VAL SER SEQRES 12 B 154 SER HIS HIS HIS HIS HIS HIS GLU PRO GLU ALA HET GOL A 201 6 HET GOL B 201 6 HET GOL B 202 6 HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 GOL 3(C3 H8 O3) FORMUL 6 HOH *150(H2 O) HELIX 1 AA1 ASN A 94 LYS A 96 5 3 HELIX 2 AA2 LYS A 107 THR A 111 5 5 HELIX 3 AA3 ASN B 94 LYS B 96 5 3 HELIX 4 AA4 LYS B 107 THR B 111 5 5 SHEET 1 AA1 4 VAL A 23 SER A 28 0 SHEET 2 AA1 4 LEU A 39 GLY A 47 -1 O SER A 42 N SER A 28 SHEET 3 AA1 4 THR A 98 LEU A 103 -1 O LEU A 103 N LEU A 39 SHEET 4 AA1 4 SER A 88 ASP A 93 -1 N THR A 89 O GLN A 102 SHEET 1 AA2 6 GLY A 31 GLN A 34 0 SHEET 2 AA2 6 THR A 137 SER A 142 1 O THR A 140 N VAL A 33 SHEET 3 AA2 6 ALA A 112 ARG A 121 -1 N TYR A 114 O THR A 137 SHEET 4 AA2 6 SER A 51 GLN A 60 -1 N SER A 51 O ARG A 121 SHEET 5 AA2 6 GLU A 67 SER A 73 -1 O ALA A 70 N TRP A 57 SHEET 6 AA2 6 THR A 78 TYR A 80 -1 O ASN A 79 N VAL A 71 SHEET 1 AA3 4 GLY A 31 GLN A 34 0 SHEET 2 AA3 4 THR A 137 SER A 142 1 O THR A 140 N VAL A 33 SHEET 3 AA3 4 ALA A 112 ARG A 121 -1 N TYR A 114 O THR A 137 SHEET 4 AA3 4 TYR A 130 TRP A 133 -1 O TYR A 130 N VAL A 120 SHEET 1 AA4 4 GLN B 24 GLY B 29 0 SHEET 2 AA4 4 LEU B 39 SER B 46 -1 O SER B 46 N GLN B 24 SHEET 3 AA4 4 THR B 98 LEU B 103 -1 O LEU B 101 N LEU B 41 SHEET 4 AA4 4 SER B 88 ASP B 93 -1 N ASP B 93 O THR B 98 SHEET 1 AA5 6 GLY B 31 VAL B 33 0 SHEET 2 AA5 6 THR B 137 VAL B 141 1 O THR B 140 N VAL B 33 SHEET 3 AA5 6 ALA B 112 ARG B 121 -1 N TYR B 114 O THR B 137 SHEET 4 AA5 6 SER B 51 GLN B 60 -1 N ASN B 53 O ASN B 119 SHEET 5 AA5 6 ARG B 66 SER B 73 -1 O VAL B 69 N TRP B 57 SHEET 6 AA5 6 THR B 78 TYR B 80 -1 O ASN B 79 N VAL B 71 SHEET 1 AA6 4 GLY B 31 VAL B 33 0 SHEET 2 AA6 4 THR B 137 VAL B 141 1 O THR B 140 N VAL B 33 SHEET 3 AA6 4 ALA B 112 ARG B 121 -1 N TYR B 114 O THR B 137 SHEET 4 AA6 4 SER B 129 TRP B 133 -1 O TYR B 130 N VAL B 120 SSBOND 1 CYS A 43 CYS A 116 1555 1555 2.05 SSBOND 2 CYS B 43 CYS B 116 1555 1555 2.02 SITE 1 AC1 10 ASP A 54 ILE A 72 SER A 73 SER A 74 SITE 2 AC1 10 SER A 92 ASP A 93 ASN A 94 ASN A 97 SITE 3 AC1 10 THR A 98 VAL A 99 SITE 1 AC2 9 ILE B 52 ASP B 54 MET B 55 ILE B 72 SITE 2 AC2 9 SER B 73 SER B 74 SER B 92 ASN B 94 SITE 3 AC2 9 ASN B 97 SITE 1 AC3 5 GLY B 29 GLY B 30 SER B 38 LEU B 39 SITE 2 AC3 5 ARG B 40 CRYST1 57.680 57.680 64.751 90.00 90.00 120.00 P 31 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017337 0.010010 0.000000 0.00000 SCALE2 0.000000 0.020019 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015444 0.00000